Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial

Erstveröffentlichung

2018

Authors

Cortes, Jorge

Perl, Alexander E.

Döhner, Hartmut

Kantarjian, Hagop

Martinelli, Giovanni

et al.

Wissenschaftlicher Artikel

Published in

Lancet Oncology ; 19 (2018), 7. - S. 889-903. - ISSN 1470-2045. - eISSN 1474-5488

Link to publication

https://dx.doi.org/10.1016/S1470-2045(18)30240-7

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[DDC subject group]: DDC 610 / Medicine & health

---

Metadata

Show full item record